In vitro comparison of antiviral drugs against feline herpesvirus 1

BMC Veterinary Research

Volumn 2, Issue , 2006, Pages

  Van Der Meulen, K ^a   Garre B ^a   Croubels, S ^a   Nauwynck, H ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

FELID HERPESVIRUS 1; FELIDAE; HUMAN HERPESVIRUS 1;

EID: 33745025540     PISSN: None     EISSN: 17466148     Source Type: Journal    
DOI: 10.1186/1746-6148-2-13     Document Type: Article

References (27)

1. Povey RC, Johnson RH: A survey of feline viral rhinotracheitis and feline picornavirus infection in Britain. J Small Anim Pract 1971, 12:233-247.
2. Cai Y, Fukushi H, Koyasu S, Kuroda E, Yamaguchi T, Hirai K: An etiological investigation of domestic cats with conjunctivitis and upper respiratory tract disease in Japan. J Vet Med Sci 2002, 64:215-219.
3. Maggs DJ: Update on pathogenesis, diagnosis, and treatment of feline herpesvirus type 1. Clin Tech Small Anim Pract 2005, 20:94-101.
4. Nasisse MP: Feline herpesvirus ocular disease. Vet Clin North Am Small Anim Pract 1990, 20:667-680.
5. Andrew SE: Ocular manifestations of feline herpesvirus. J Feline Med Surg 2001, 3:9-16.
6. Sussman MD, Maes RK, Kruger JM, Spatz SJ, Venta PJ: A feline herpesvirus-1 recombinant with a deletion in the genes for glycoproteins gl and gE is effective as a vaccine for feline rhinotracheitis. Virology 1995, 214:12-20.
7. Scott FW, Geissinger CM: Long-term immunity in cats vaccinated with an inactivated trivalent vaccine. Am J Vet Res 1999, 60:652-658. Erratum in: Am J Vet Res 1999, 60:763
8. Gaskell RM, Povey RC: Experimental induction of feline viral rhinotracheitis virus re-excretion in FVR-recovered cats. Vet Rec 1977, 100:128-33.
9. Williams DL, Fitzmaurice T, Lay L, Forster K, Hefford J, Budge C, Blackmore K, Robinson JC, Field HF: Efficacy of antiviral agents in feline herpetic keratitis: results of an in vitro study. Curr Eye Res 2004, 29:215-218.
10. Maggs DJ, Clarke HE: In vitro efficacy of ganciclovir, cidofovir, penciclovir, foscarnet, idoxuridine, and acyclovir against feline herpesvirus type-1. Am J Vet Res 2004, 65:399-403.
11. Nasisse MP, Guy JS, Davidson MG, Sussman W, De Clercq E: In vitro susceptibility of feline herpesvirus-1 to vidarabine, idoxuridine, trifluridine, acyclovir, or bromovinyldeoxyuridine. Am J Vet Res 1989, 50:158-160.
12. Mikloska Z, Cunningham AL: Alpha and gamma interferons inhibit herpes simplex virus type 1 infection and spread in epidermal cells after axonal transmission. J Virol 2001, 75:11821-11826.
13. Jenssen H, Andersen JH, Mantzilas D, Gutteberg TJ: A wide range of medium-sized, highly cationic, alpha-helical peptides show antiviral activity against herpes simplex virus. Antiviral Res 2004, 64:119-126.
14. De Clercq E: Antiviral durgs: current state of the art. J Clin Virol 2001, 22:73-89.
15. Galle LE: Antiviral therapy for ocular viral disease. Vet Clin North Am Small Anim Prac 2004, 34:639-653.
16. Neirinckx E, Garré B, Nauwynck H, Croubels S, De Backer P, van der Meulen KM: Antivirale behandeling van rhinotracheïtisvirus, immunodeficientievirus en leukemievirus infecties bij de kat. Flemish Veterinary Journal 2005, 74:420-431.
17. Weiss RC: Synergistic antiviral activities of acyclovir and recombinant human leukocyte (alpha) interferon on feline herpesvirus replication. Am J Vet Res 1989, 50:1672-1677.
18. Kramata P, Downey KM: 9-(2-phosphonylmethoxyethyl) derivatives of purine nucleotide analogs: A comparison of their metabolism and interaction with cellular DNA synthesis. Mol Pharmacol 1999, 56:1262-1267.
19. Sutton D, Boyd MR: Comparative activity of penciclovir and acyclovir in mice infected intraperitoneally with herpes simplex virus type 1 SC16. Antimicrob Agents Chemother 1993, 37:642-645.
20. Balzarini J, Degreve B, Andrei G, Neyts J, Sandvold M, Myhren F, de Clercq E: Superior cytostatic activity of the ganciclovir elaidic acid ester due to the prolonged intracellular retention of ganciclovir anabolites in herpes simplex virus type 1 thymidine kinase gene-transfected tumor cells. Gene Ther 1998, 5:419-426.
21. Merta A, Votruba I, Jindrich J, Holy A, Cihlar T, Rosenberg I, Otmar M, Herve TY: Phosphorylation of 9-(2-phosphonomethoxyethyl) adenine and 9-(S)-(3-hydroxy-2-phosphonomethoxypropyl) adenine by AMP(dAMP) kinase from L1210 cells. Biochem Pharmacol 1992, 44:2067-2077.
22. Robbins BL, Greenhaw J, Connelly MC, Fridland A: Metabolic pathways for activation of the antiviral agent 9-(2-phosphonylmethoxyethyl) adenine in human lymphoid cells. Antimicrob Agents Chemother 1995, 39:2304-2308.
23. Sandmeyer LS, Keller CB, Bienzle D: Effects of cidofovir on cell death and replication of feline herpes virus-1 in cultured feline corneal epithelial cells. Am J Vet Res 2005, 66:217-222.
24. Vahlenkamp TW, De Ronde A, Balzarini J, Naesens L, De Clercq E, van Eijk MJ, Horzinek MC, Egberink HF: (R)-9-(2-phosphonylmethoxypropyl)-2, 6-diaminopurine is a potent inhibitor of feline immunodeficiency virus infection. Antimicrob Agents Chemother 1995, 39:746-749.
25. Hartmann K, Donath A, Beer B, Egberink HF, Horzinek MC, Lutz H, Hoffmann-Fezer G, Thum I, Thefeld S: Use of two virustatica (AZT, PMEA) in the treatment of FIV and of FeLV seropositive cats with clinical symptoms. Vet Immunol Immunopathol 1992, 35:167-175.
26. Horimoto T, Limcumpao JA, Tohya Y, Takahashi E, Mikami T: Feline herpesvirus type 1 glycoproteins eliciting virus neutralizing and hemagglutination-inhibiting antibodies. Arch Virol 1990, 111:127-32.
27. van der Meulen KM, Caij AB, Nauwynck HJ, Pensaert MB: Absence of viral proteins in equine herpesvirus 1-infected blood mononuclear cells during cell-associated viremia. Vet Microbiol 2006, 113:265-73.